Nanjing, China

Yun Ge

This inventor holds 1 USPTO granted patent. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Shouyao Holdings (Beijing) Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yun Ge. Retrieved from https://idiyas.com/inventor/yun-ge-100y3pwf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yun Ge

Introduction

Yun Ge is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of protein inhibitors. His work is characterized by a focus on innovative solutions for treating diseases mediated by BET proteins.

Latest Patents

Yun Ge holds a patent for a crystal form and salt form of a bromine domain protein inhibitor. This invention includes a preparation method and highlights the use of these forms in the development of drugs aimed at treating specific diseases. The patent is represented by the formula (I) and showcases his expertise in medicinal chemistry.

Career Highlights

Throughout his career, Yun Ge has worked with prominent companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Shouyao Holdings (Beijing) Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.

Collaborations

Yun Ge has collaborated with talented individuals in his field, including Zhenliang Shan and Yingya Zhang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yun Ge's contributions to the field of pharmaceuticals through his patent and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…